Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice

This study suggested that ADAMTS13 protein and other VWF-targeting agents may be a novel therapeutic option for treatment of pulmonary inflammatory diseases.PMID:37759076 | DOI:10.1007/s12185-023-03668-x
Source: International Journal of Hematology - Category: Hematology Authors: Source Type: research